Full Name
Eng King Tan
Variants
Tan, E.-K.
Tan, E.K.
 
 
 
Email
gmstek@nus.edu.sg
 

Results 221-240 of 414 (Search time: 0.022 seconds).

Issue DateTitleAuthor(s)
2212019Large-Scale Whole-Genome Sequencing of Three Diverse Asian Populations in SingaporeWu, D.; Dou, J.; Chai, X.; Bellis, C.; Wilm, A.; Shih, C.C.; Soon, W.W.J.; Bertin, N.; Lin, C.B.; Khor, C.C.; DeGiorgio, M.; Cheng, S.; Bao, L.; Karnani, N. ; Hwang, W.Y.K.; Davila, S. ; Tan, P. ; Shabbir, A.; Moh, A.; Tan, E.-K. ; Foo, R.S.Y. ; Goh, L.L.; Leong, K.P.; Foo, R.S.Y.; Lam, C.S.P. ; Richards, A.M. ; Cheng, C.-Y. ; Aung, T. ; Wong, T.Y. ; Ng, H.H. ; SG10K Consortium; Liu, J. ; Wang, C.
22003Levodopa-induced oromandibular dystonia in progressive supranuclear palsyTan E.K. ; Chan L.L. ; Wong M.C. 
3Oct-2009Lingo1 variant increases risk of familial essential tremorTan, E.-K. ; Teo, Y.-Y. ; Prakash, K.-M.; Li, R.; Lim, H.-Q.; Angeles, D.; Tan, L.-C.; Au, W.-L.; Yih, Y.; Zhao, Y.
42011Lingo2 variants associated with essential tremor and Parkinson's diseaseWu Y.-W.; Prakash K.M. ; Rong T.-Y.; Li H.-H. ; Xiao Q.; Tan L.C. ; Au W.-L. ; Ding J.-Q.; Chen S.-D.; Tan E.-K. 
52016Linking a genome-wide association study signal to a LRRK2 coding variant in Parkinson's diseaseFoo J.N.; Chung S.J.; Tan L.C.; Liany H.; Ryu H.-S.; Hong M.; Koh T.H.; Irwan I.D.; Au W.-L.; Prakash K.-M.; Aung T. ; Cheng C.-Y. ; Chong S.-A. ; Khor C.C. ; Lee J. ; Tai E.-S. ; Vithana E.N. ; Wong T.-Y. ; Song K.; Liu J. ; Tan E.-K. 
62016Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson's disease (PD)Zhou Z.D.; Sathiyamoorthy S.; Angeles D.C.; Tan E.K. 
715-May-2024Linking Factors Associated with Constipation in ObesityTan, Brendan Jen-Wei; Chan, Ling-Ling ; Tan, Eng-King ; Zhou, Zhi-Dong
82010Linking LINGO1 to essential tremorTan E.-K. 
92012Linking restless legs syndrome with Parkinson's disease: clinical, imaging and genetic evidencePeeraully T.; Tan E.-K. 
102017Linking statins and lipids in Parkinson's diseaseNg A.S.L. ; Tan E.-K. 
112009Long-term treatment outcome with different formulations of botulinum toxinPerez-Saldana M.T.; Tan E.K. ; Burguera J.A.
1210-Jul-2012LRRK2 A419V is not associated with Parkinson's disease in different Chinese populationsWu, Y.R.; Tan, L.C.; Fu, X.; Chen, C.M.; Au, W.L.; Chen, L.; Chen, Y.C.; Prakash, K.M.; Zheng, Y.; Lee-Chen, G.-J.; Zhao, Y.; Zeng, J.-S.; Tan, E.K. ; Pei, Z.
13Apr-2011LRRK2 as a therapeutic target in Parkinson's diseaseTan, E.K. ; Schapira, A.H.
142006LRRK2 G2019S and I2020T mutations are not common in Alzheimer's disease and vascular dementiaLee E.; Hui S.; Ho G.; Tan E.K. ; Chen C.P.
152007LRRK2 G2019S founder haplotype in the Chinese populationTan E.-K. ; Skipper L.; Tan L. ; Liu J.-J.
162014LRRK2 G2385R and R1628P Mutations Are Associated with an Increased Risk of Parkinson's Disease in the Malaysian PopulationGopalai A.A.; Lim S.-Y.; Chua J.Y.; Tey S.; Lim T.T.; Mohamed Ibrahim N.; Tan A.H.; Eow G.B.; Abdul Aziz Z.; Puvanarajah S.D.; Viswanathan S.; Looi I.; Lim S.K.; Tan L.P.; Chong Y.B.; Tan C.T.; Zhao Y.; Tan E.K. ; Ahmad-Annuar A.
172009LRRK2 in Parkinson's disease: Genetic and clinical studies from patientsKumari U.; Tan E.K. 
182017LRRK2 interacts with ATM and regulates Mdm2-p53 cell proliferation axis in response to genotoxic stressChen Z. ; Cao Z.; Zhang W.; Gu M. ; Zhou Z.D. ; Li B.; Li J.; Tan E.K. ; Zeng L. 
192008Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson diseaseHaugarvoll K.; Rademakers R.; Kachergus J.M.; Nuytemans K.; Ross O.A.; Gibson J.M.; Tan E.-K. ; Gaig C.; Tolosa E.; Goldwurm S.; Guidi M.; Riboldazzi G.; Brown L.; Walter U.; Benecke R.; Berg D.; Gasser T.; Theuns J.; Pals P.; Cras P.; De Deyn P.P.; Engelborghs S.; Pickut B.; Uitti R.J.; Foroud T.; Nichols W.C.; Hagenah J.; Klein C.; Samii A.; Zabetian C.P.; Bonifati V.; Van Broeckhoven C.; Farrer M.J.; Wszolek Z.K.
20Oct-2008Lrrk2 R1628P in non-Chinese Asian racesTan, E.-K. ; Tang, M.; Tan, L.C.; Wu, Y.-R.; Wu, R.-M.; Ross, O.A.; Zhao, Y.